从2020年到2023年,中国东部艾滋病毒耐药性的流行病学动态和分子特征
Min Zhu1, Zhou Sun1, Xingliang Zhang1
1Department of HIV/AIDS Control and Prevention, Hangzhou Center for Disease Control and Prevention (Hangzhou Health Supervision Institution), Hangzhou, China.
Frontiers in microbiology
|November 4, 2024
概括
艾滋病毒耐药性是一个越来越令人担忧的问题,8.4%的新感染显示出治疗前耐药性,特别是对NNRTIs. 有针对性的干预措施对于控制耐药性HIV菌株至关重要.
科学领域:
- 流行病学 流行病学
- 病毒学 病毒学
- 公共卫生 公共卫生
背景情况:
- 艾滋病毒抗药性 (HIVDR) 对全球艾滋病流行病控制构成重大威胁.
- 抗逆转录病毒疗法 (ART) 的扩大增加了HIVDR的风险.
- 了解耐药性模式对于有效的艾滋病毒管理至关重要.
研究的目的:
- 调查HIV治疗前耐药性 (PDR) 的流行病学动态.
- 描述PDR和获得药物耐药性 (ADR) 的分子方面.
- 分析中国杭州的HIVDR,这是一个主要的发达地区.
主要方法:
- 从2020年到2023年进行了一项流行病学调查.
- 包括3,596例新诊断的艾滋病毒感染病例和164例ART失败病例.
- 利用分子传输网络和贝叶斯分析来识别和追踪电阻集群.
主要成果:
- 整体PDR患病率为8.4%,非核酸逆转录酶抑制剂 (NNRTIs) 受到影响最多 (4.7%).
- CRF07_BC亚型的PDR显著高于CRF08_BC.
- 鉴定了Q58E和K103N突变的传播,集群起源于2005-2012年间的深. 在ART失败病例中,ADR患病率为50.6%.
结论:
- 针对特定的亚型和传播集群进行有针对性的干预是必要的,以对抗耐药性HIV.
- 持续监测HIV耐药性模式对于优化ART策略至关重要.
- 早期发现和干预可以减轻HIVDR的影响.
更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
427
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
31.5K
相关概念视频
Retrovirus Life Cycles
45.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.7K
Viral Mutations
32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
